Our top pick for
Low costs
Finder Award
Cronos Australia is a pharmaceuticals business based in Australia. Cronos Australia shares (CAU) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Cronos Australia has a trailing 12-month revenue of around $67 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Cronos Australia
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Cronos Australia. Find the share by name or ticker symbol: CAU. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cronos Australia reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Cronos Australia. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
Education & learning
Finder Award
Our top pick for
Australian stocks
Finder Award
What's in this guide?
- Cronos Australia key stats
- Compare share trading platforms
- Is Cronos Australia stock a buy or sell?
- Cronos Australia performance over time
- Are Cronos Australia shares over-valued?
- Cronos Australia's financials
- How volatile are Cronos Australia shares?
- Does Cronos Australia pay a dividend?
- Other common questions
Cronos Australia stock price (ASX:CAU)
Use our graph to track the performance of CAU stocks over time.Cronos Australia shares at a glance
Information last updated 2023-07-13.
| 52-week range | $0.315 - $0.72 |
|---|---|
| 50-day moving average | $0.5683 |
| 200-day moving average | $0.498 |
| Target price | $1 |
| PE ratio | 54 |
| Dividend yield | $0.01 (1.85%) |
| Earnings per share (TTM) | $0.01 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
1 - 6 of 6
Is it a good time to buy Cronos Australia stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Cronos Australia price performance over time
Historical closes compared with the last close of A$0.36
| 1 year (2022-11-29) | -41.94% |
|---|---|
| 2 years (2021-11-29) | 84.62% |
| 3 years (2020-11-27) | 200.00% |
Is Cronos Australia under- or over-valued?
Valuing Cronos Australia stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cronos Australia's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cronos Australia's P/E ratio
Cronos Australia's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 54x. In other words, Cronos Australia shares trade at around 54x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Cronos Australia's EBITDA
Cronos Australia's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $10.1 million (£0.0 million).
The EBITDA is a measure of a Cronos Australia's overall financial performance and is widely used to measure a its profitability.
Cronos Australia financials
| Revenue TTM | $67 million |
|---|---|
| Operating margin TTM | 14.81% |
| Gross profit TTM | $25.4 million |
| Return on assets TTM | 24% |
| Return on equity TTM | 40.03% |
| Profit margin | 8.98% |
| Book value | 0.047 |
| Market capitalisation | $300.5 million |
TTM: trailing 12 months
Cronos Australia share dividends
Dividend payout ratio: 100% of net profits
Recently Cronos Australia has paid out, on average, around 100% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.85% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Cronos Australia shareholders could enjoy a 1.85% return on their shares, in the form of dividend payments. In Cronos Australia's case, that would currently equate to about A$0.01 per share.
Cronos Australia's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 16 September 2022 (the "ex-dividend date").
Cronos Australia share price volatility
Over the last 12 months, Cronos Australia's shares have ranged in value from as little as $0.315 up to $0.72. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Cronos Australia's is 0.0683. This would suggest that Cronos Australia's shares are less volatile than average (for this exchange).
Cronos Australia overview
Cronos Australia Limited engages in the sale and distribution of medicinal cannabis products, and operation of medicinal cannabis clinic businesses in Australia and Asia. It operates through three segments: Medical, Clinics, and Consumer. The company sells its medicinal cannabis products under the Adaya brand, as well as through online marketplace platform. It also offers hemp seed oil personal care consumer products under the Bathing Shed brand; and CBD-based products under the FCTR and Saiph brands. The company was incorporated in 2018 and is based in South Yarra, Australia.
Cronos Australia in the news
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to buy OpenAI stock in Australia
Looking to jump on the AI bandwagon? Here's how you can invest in ChatGPT and its parent company OpenAI from Australia.
-
Best performing stocks on the ASX in 2023 (Updated weekly)
Looking for the best performing stocks in Australia? We update this list weekly.
-
Cryptocurrency ETFs explained: A simple guide for investors (2023)
If you’re looking for ways to gain exposure to Bitcoin and other digital currencies, cryptocurrency ETFs could be worth exploring. Find out what crypto ETFs are and how they work in this introductory guide.
-
How to buy Gol Linhas Aereas Inteligentes SA ADR (GOL) shares in Australia
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
-
How to buy Microsoft (MSFT) shares in Australia
Steps to owning and managing Microsoft shares from in Australia.
-
A beginner’s guide to Lego investing
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
-
The cheapest stock brokers in Australia (Nov 2023)
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
-
What is the money market?
Learn about the money market and everyday consumer money market products.
-
Is investing in crowdfunding a safe investment?
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
-
The best trading platforms in Australia for 2023
Follow these tips to find the best share trading platform for you.
Ask an Expert
